Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase 1/2, First-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors

This study, the first clinical trial of AVZO-1418, aims to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, maximum tolerated dose, and …

Solid Tumor CancerLocally AdvancedMetastatic Solid Tumors+5 more

Estimated

~$10 – $8,750

Avenzo Therapeutics, Inc.NCT07038343